Neogen Chemicals

DCM Shriram, G-Tec Janix Education, Neogen, Aion-Tech and Bartronics India saw over 13-fold jump in trading volume as the stocks zoomed up to 20 per cent on Thursday, shows NSE data.

Q1FY26 company results: Balaji Amines, Neogen Chemicals, Medplus Health Services, and Advanced Enzyme Technologies are also to release their April-June quarter earnings reports today

The management is confident of achieving FY26 revenue guidance of Rs 950-1,000 crore in the standalone business; beyond FY26, the rapid scale up in Neogen Ionics will drive consolidated performance

Neogen Chemicals share price zoomed up to 6.06 per cent at Rs 2,345 per share intraday on the BSE

The stock of the specialty chemicals maker is trading higher for the sixth straight day, surging 40 per cent during the period.

Neogen Chemicals will raise Rs 253 crore through an issue of preferential shares to investors to expand business. In a regulatory filing on Wednesday, the company informed that the Board of Directors considered and approved the allotment of 14,42,358 equity shares of face value of Rs 10 each at a price of Rs 1754.07 per share, aggregating up to Rs 252.99 crore on a preferential basis. SBI Large and Midcap Fund, SBI Contra Fund, SBI Equity Savings Fund, Quant Small Cap Fund, TATA India Tax Saving Fund, India Acorn Fund Ltd, Ashoka India Equity Investment Trust PLC, Invesco India Small Cap Fund and Alchemy Long term Ventures Fund have been allotted these preference shares. The equity shares allotted by the company to these investors will be listed on the stock exchanges. "The company is in the business of manufacturing specialty Chemicals. The Company anticipates growth opportunities in its existing organic/ inorganic business and continues to evaluate various avenues for growth and

This acquisition will help Neogen to strengthen its position in the electrolyte market in India.

Shares of Neogen Chemicals have more than doubled in the past one-year period after the Centre announced production-linked incentives (PLIs) for specialty chemical manufacturers.

The markets may consolidate after two days of strong gains for the benchmark indices

The broader markets also weakened towards the end of the trade, and the BSE Midcap and Smallcap indices ended with a loss of 1.4 per cent each

Telecom shares may be in demand on credit of bank guarantee to the telcos

Neogen's business has some seasonal drivers, due to which the company tends to deliver stronger financial performance in the second half of the financial year

HDFC Securities believes the improvement in the share of custom synthesis manufacturing and advanced intermediates will result in strengthening of the balance sheet and manifest earnings visibility

The initial public offer (IPO) of Neogen Chemicals, which ran between April 24 and April 26, received huge response from the investors as the issue was overall subscribed 41.18 times.

The initial public offering of Neogen Chemicals received good response from investors as the issue was subscribed 41.14 times on the final day of bidding Friday. The Rs 132-crore initial public offering (IPO) received bids for 17,80,95,125 shares against the total issue size of 43,29,038 shares, according to an update on the NSE at 19:30 hrs. The category reserved for qualified institutional buyers (QIBs) was subscribed 30.42 times, non-institutional investors 114.73 times and retail individual investors 15.67 times, said merchant banking sources. The IPO comprises a fresh issue of up to Rs 70 crore and an offer-for-sale of up to 29,00,000 equity shares, including an anchor portion of 18,46,715 equity shares. The price range for the offer, which was opened for subscription on Wednesday, has been fixed at Rs 212-215 per share. Inga Advisors Pvt Ltd and Batlivala & Karani Securities India Pvt Ltd are the book-running lead managers to the offer. Equity shares of the company are ...

The IPO also comprises of secondary share sale worth Rs 69 crore by the promoter group